Summary:
Summary Statement of Deficiencies D2016 SUCCESSFUL PARTICIPATION CFR(s): 493.803(a)(b)(c) (a) Each laboratory performing nonwaived testing must successfully participate in a proficiency testing program approved by CMS, if applicable, as described in subpart I of this part for each specialty, subspecialty, and analyte or test in which the laboratory is certified under CLIA. (b) Except as specified in paragraph (c) of this section, if a laboratory fails to participate successfully in proficiency testing for a given specialty, subspecialty, analyte or test, as defined in this section, or fails to take remedial action when an individual fails gynecologic cytology, CMS imposes sanctions, as specified in subpart R of this part. (c) If a laboratory fails to perform successfully in a CMS- approved proficiency testing program, for the initial unsuccessful performance, CMS may direct the laboratory to undertake training of its personnel or to obtain technical assistance, or both, rather than imposing alternative or principle sanctions except when one or more of the following conditions exists: (1) There is immediate jeopardy to patient health and safety. (2) The laboratory fails to provide CMS or a CMS agent with satisfactory evidence that it has taken steps to correct the problem identified by the unsuccessful proficiency testing performance. (3) The laboratory has a poor compliance history. This CONDITION is not met as evidenced by: Based on the desk review of hematology proficiency testing results from the Medical Laboratory Evaluation (MLE) on 12/01/2021, the laboratory failed to successfully participate in two (2) consecutive hematology testing events. See D 2131 D2131 HEMATOLOGY CFR(s): 493.851(g) Failure to achieve an overall testing event score of satisfactory performance for two consecutive testing events or two out of three consecutive testing events is Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- unsuccessful performance. This STANDARD is not met as evidenced by: Based on the desk review of proficiency testing results from the Medical Laboratory Evaluation on 12/1/2021, the laboratory failed to achieve satisfactory overall Hematology testing event scores in two (2) consecutive testing events. Findings include: 1. The laboratory failed to achieve a satisfactory score for the Cell ID or WBC Diff in the second (2nd) of 2021 with a score of sixty percent (60%). 2. The laboratory failed to achieve a satisfactory score for the Cell ID or WBC Diff in the third (3rd) event of 2021 with a score of zero percent (0%). 3. The laboratory failed to achieve a satisfactory score for the Red Blood Cell (RBC) in the second (2nd) event of 2021 with a score of forty percent (40%). 4. The laboratory failed to achieve a satisfactory score for the Red Blood Cell (RBC) in the third (3rd) event of 2021 with a score of zero percent (0%). 5. The laboratory failed to achieve a satisfactory score for the Hematocrit (Hct) in the second (2nd) event of 2021 with a score of forty percent (40%). 6. The laboratory failed to achieve a satisfactory score for the Hematocrit (Hct) in the third (3rd) event of 2021 with a score of zero percent (0%). 7. The laboratory failed to achieve a satisfactory score for the Hemoglobin (Hgb) in the second (2nd) event of 2021 with a score of forty percent (40%). 8. The laboratory failed to achieve a satisfactory score for the Hemoglobin (Hgb) in the third (3rd) event of 2021 with a score of zero percent (0%). 9. The laboratory failed to achieve a satisfactory score for the White Blood Cell (WBC) in the second (2nd) event of 2021 with a score of twenty percent (20%). 10. The laboratory failed to achieve a satisfactory score for the White Blood Cell (WBC) in the third (3rd) event of 2021 with a score of zero percent (0%). -- 2 of 2 --